My response is based on what I’ve heard Saylor say regarding the subject, but basically it boils down to this:
They can’t compete with their competitors like Oracle and IBM when it comes to R&D spend, or employee acquisition/retention based on their primary business model of enterprise software. Essentially they were a business doomed to fail prior to the bitcoin treasury strategy.
By adopting bitcoin as a treasury reserve asset, they have a way to preserve their cash flows in an instrument that will appreciate against the value of their cashflows, which will increase their equity value, allowing them to sell more shares to fund whatever they want to fund, which seems to primarily be buying more bitcoin.
Now, you’re right in that there is shareholder dilution, but the goal is to have the bitcoin acquisition increase the value of the company more than the shares are diluted, similar to the acquisition of a business which provides more value to shareholders than the opportunity cost of acquiring that company, I.e. his goal is to make the purchase in of bitcoin an accretive endeavor for shareholders. So far, this has been the case.
He has essentially positioned the company to be a bitcoin investment vehicle more so than an enterprise software company. Institutional investors that can’t buy bitcoin can buy microstrategy stock and therefor get leveraged exposure to the underlying asset. They just take on counterparty risk regarding how microstrategy custodies their bitcoin. But essentially, they’re a leveraged bitcoin etf that has underlying cash flow from an enterprise software company rather than charging a management fee like a traditional ETF would.